We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Non-Invasive Technology Monitors Cardiac Output

By HospiMedica staff writers
Posted on 05 Feb 2008
A highly accurate, portable cardiac output monitor provides a noninvasive window to cardiac and hemodynamic function. More...


The Cheetah Reliant monitor provides continuous tracking of cardiac output and other key parameters of cardiac function such as ventricular ejection time, heart rate (HR), and cardiac contractility. The system is based on noninvasive cardiac output monitoring (NICOM) technology, which uses traditional impedance technology that analyzes changes in voltage of electrical currents traversing the patient's chest, in combination with proprietary bioreactance technology, which analyzes frequency related effects. The hybrid analysis helps deal with electrical noise interference, patient movement, respiration, and electrode misplacement.

As a result, NICOM enables a highly precise, accurate, and responsive measurement of cardiac function and hemodynamic status. The system can be used in various clinical settings, including hemodynamic monitoring, heart failure, perioperative care, and hemodialysis, as well as outpatient applications such as cardio-pulmonary-stress testing (CPX) for chronic heart failure (CHF) evaluation and during optimization of bi-ventricular pacemakers. The Cheetah Reliant monitor is a product of Cheetah Medical (Tel Aviv, Israel), and has been approved by the U.S. Food and Drug Administration (FDA).

"Across the world, the healthcare environment struggles to provide quality care to an aging population while dealing with efficiency and economic constraints,” said Yoav Avidor, M.D., CEO of Cheetah Medical. "There is a global push to reduce invasive, costly procedures that can lead to complications and require a highly skilled physician to deploy. Hospitals seek better solutions in terms of efficiency, cost and scalability to more patients who can be treated in less acute settings, without impacting quality of care.”

Cardiac output monitoring has been shown in the context of specific treatment algorithms to reduce morbidity, mortality, and length of hospital stay in a number of conditions including perioperative care, intensive care, and trauma while also providing clinical value in heart failure and dialysis.


Related Links:
Cheetah Medical

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
ECG Management System
NEMS Web
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.